News coverage of drug-contaminated water samples in Philadelphia and 24 other U.S. ... Daughton and Ilene Sue Ruhoy. Drug Safety 2008; 31(12): 1069-1082. White House Office of National Drug Control Policy position statement.
Symptoms include a growing shortage in primary care doctors, out-of-control malpractice premiums, onerous rules and regulations with more sure to follow, and now, conflicting advice on drug safety as ... the Senate is accusing the FDA of either bias or
These side effects were not seen in many of the initial studies, but in later on via reports by doctors and patients after the drug was on the market. ... This method is called post-market surveillance. Post-market surveillance is critical in determining
Electronic prescribing has improved drug safety by automating cross-checking and alerting prescribers when two drugs interact. ... The FDA website offers a drug Index of Postmarket Safety Information for Patients and Providers.
Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms (FDA Drug Safety Communication).
A drug safety communication about over-the-counter acne products (including Proactiv, Neutrogena, MaxClarity, Oxy, Ambi, Aveeno, Clean & Clear) and the risk of rare but potentially life-threatening allergic reactions or ... The agency will, however,
First, we need to subtract out those that work but come with an unacceptable safety profile (e.g. ... Isolating and refining the active ingredient through the pharmaceutical development process allows us both to improve drug safety, and to better control
Recent drug recalls have intensified concerns over the safety and effectiveness of generic versus brand-name medications, but generic drugs remain safe overall, experts say. ... Choudhry. “Recent events bring up legitimate safety concerns that we need
QD: News Every Day--Bad ads biggest fault is a lack of safety information. ... An advertisement containing no specific efficacy claim, no quantification of drug safety and no verifiable references would adhere fully to FDA guidelines, despite presenting
But SGLT2 inhibitors have recently been linked to 20 cases of diabetic ketoacidosis (DKA), as noted in a May 15 drug safety communication from the FDA. ... start. A patient who knows you will update them as information accumulates is a partner in